KORU Medical Systems, Inc. will report its second quarter 2026 financial results on Wednesday, August 5, 2026. The company's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

Participants in the U.S. or Canada can access the conference call by dialing (877)-407-0784. International callers may dial (201)-689-8560. A live and archived webcast of the event will be available via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com . The archived webcast will be accessible for six months.

About KORU Medical Systems

KORU Medical develops, manufactures, and commercializes subcutaneous infusion solutions. The Freedom Syringe Infusion System currently includes the Freedom60 and FreedomEDGE Syringe Infusion Drivers, Precision Flow Rate Tubing, and High-Flo Subcutaneous Safety Needle Sets. The system, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility and clinical trials during the drug development process.